The team visited London, UK to present their work at the 20th annual network meeting of the International Spinal Research Trust. Many thanks to the organizers for a spectacular meeting, great discussions and the chance to see the very latest in advances in the field.
Lana Zholudeva's review on Spinal Interneurons and Plasticity following Spinal Cord Injury is now out in this months issue of Trends in Neurosciences
Our new paper reveals that transplanting V2a spinal interneurons into the injured cervical spinal cord improves breathing. Congratulations to Lana Zholudeva on this really nice paper! Its a really interesting study, but its the tip of the iceberg. We are still learning how to best harness these cells for therapies.
Margo presented her latest work to colleagues at the Neurobiology Research in Progress (Drexel College of Medicine).
The first Philadelphia Consortium Think Tank was held on Friday, organized by Drs. MJ Mulcahey and Steve Williams. It was a successful day of collaborative ideas and research planning with the goal of optimizing spinal cord injury research programs. Philadelphia is a hub for SCI research, neurosurgery, neuroradiology and rehabilitation. We look forward to seeing the Consortium strengthen the research being done.
A huge thanks to Lana Zholudeva and Margo Randelman who represented the research team at 2 conferences in Florida: the 2nd Intermittent Hypoxia Retreat in Gainesville, and the combined International Symposium on Neural Transplantation and Restoration (INTR) / American Society for Neural Therapy and Repair, in Clearwater Florida. Congratulations both Margo and Lana for receiving travel awards, and especially to Lana for being invited to give a platform presentation at INTR!
The 15th International Symposium on Neural Transplantation and Restoration (INTR), and the 26th annual meeting of the American Society for Neural Therapy and Repair (ASNTR), kicked off in Clearwater, Florida. The meeting is being attended by internationally renowned experts in neural transplantation and repair.
Tanya Bezdudnaya has a paper now online that documents the extent of spontaneous plasticity that can occur following pre-clinical SCI
The first in a series of papers from our team that will be coming out in 2018:
Integration of Transplanted Neural Precursors with the Injured Spinal Cord. - PubMed - NCBI https://www.ncbi.nlm.nih.gov/pubmed/29295654
It was a pleasure hosting Matthew Rodreick from Unite 2 Fight Paralysis in our lab yesterday!
Many thanks to Roman Reed for making time to spend the whole day with me in San Francisco. Great discussions and great planning session.
In the last week of November, our research team attended the biennial International Symposium on Neural Regeneration. It was an excellent meeting as always! Great to speak with so many people within the field! Congratulations also go to Lana Zholudeva for winning a presentation award for her research on transplantation of V2a spinal interneurons to repair the injured cervical spinal cord.
Congratulations to Lana Zholudeva for being awarded the 2017 Dean's Fellowship for Excellence in Collaborative or Themed Research!
Our research team was awarded funding from the Wallace H. Coulter Foundation and the Lisa Dean Moseley Foundation, to pursue cell therapy studies for promoting spinal cord repair. Our many thanks to these foundations for supporting our research!
Drexel University, College of Medicine holds a Neuroscience Summer Camp for high school juniors and sophomore students, who demonstrate a strong interest in neuroscience research. The Camp teaches students neurobiology and offers the opportunity to gain hand-on experience with ongoing research.
Each year, a group of students works with the Lane Lab research team on a spinal cord injury research project. This years team of students used viral tracing methods to examine the phrenic neuronal circuitry within the normal and injured spinal cord.
Lana Zholudeva published results now showing that spinal V2a interneurons are recruited into injured pathways after spinal cord injury. Ongoing work now aims to harness therapeutically target this cell type.